Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07267650Not yet recruiting
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Turgutlu State Hospital. Primary endpoint: Postoperative Pain Score with Movement at 48 hours. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07267650.